Analysis of various biomarkers in DIC patients with hypercytokinemia after hematopoietic stem cell transplantation

Analysis of various biomarkers in DIC patients with hypercytokinemia after hematopoietic stem cell transplantation - Analysis of various biomarkers in DIC patients with hypercytokinemia after hematopoietic stem cell transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007394

Enrollment

150

Registered

2012-02-28

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stem cell transplantation

Interventions

Ricomudurin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) stem cell transplantation 2) Written Informed Consent

Exclusion criteria

Exclusion criteria: Decision of ineligibility by a physician.

Design outcomes

Primary

Measure	Time frame
Analysis of biomarkers	—

Secondary

Measure	Time frame
efficacy of rTM	—

Countries

Japan

Contacts

Public ContactShosaku Nomura

Kansai Medical University First Department of Internal Medicine

nomurash@hirakata.kmu.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026